These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17203013)

  • 1. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers.
    Zack M; Poulos CX
    Neuropsychopharmacology; 2007 Aug; 32(8):1678-86. PubMed ID: 17203013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers.
    Zack M; Poulos CX
    Neuropsychopharmacology; 2004 Jan; 29(1):195-207. PubMed ID: 14571257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls.
    Tremblay AM; Desmond RC; Poulos CX; Zack M
    Addict Biol; 2011 Jul; 16(3):467-84. PubMed ID: 20331559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity.
    Zack M; Poulos CX
    J Psychopharmacol; 2009 Aug; 23(6):660-71. PubMed ID: 18583430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsivity moderates the effects of dopamine D2 and mixed D1-D2 antagonists in individuals with gambling disorder.
    Zack M; Lobo D; Biback C; Fang T; Smart K; Tatone D; Kalia A; Digiacomo D; Kennedy JL
    J Psychopharmacol; 2019 Aug; 33(8):1015-1029. PubMed ID: 31219367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal modulation of reward versus punishment learning by a dopamine D2-receptor antagonist in pathological gamblers.
    Janssen LK; Sescousse G; Hashemi MM; Timmer MH; ter Huurne NP; Geurts DE; Cools R
    Psychopharmacology (Berl); 2015 Sep; 232(18):3345-53. PubMed ID: 26092311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel role for the dopamine D1 receptor in gambling and amphetamine reinforcement in healthy volunteers.
    Zack MH; Lobo DS; Biback C; Fang T; Smart K; Tatone D; Kalia A; Digiacomo D; Kennedy JL
    J Psychopharmacol; 2017 Jan; 31(1):31-42. PubMed ID: 27624149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified Striatal Responses to Near-Miss Outcomes in Pathological Gamblers.
    Sescousse G; Janssen LK; Hashemi MM; Timmer MH; Geurts DE; Ter Huurne NP; Clark L; Cools R
    Neuropsychopharmacology; 2016 Sep; 41(10):2614-23. PubMed ID: 27006113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls.
    Goudriaan AE; Oosterlaan J; de Beurs E; van den Brink W
    Brain Res Cogn Brain Res; 2005 Apr; 23(1):137-51. PubMed ID: 15795140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers.
    Smart K; Desmond RC; Poulos CX; Zack M
    Neuropharmacology; 2013 Oct; 73():66-74. PubMed ID: 23711549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological correlates of slot machine win size in pathological gamblers.
    Dixon MR; Wilson A; Habib R
    Behav Processes; 2014 May; 104():108-13. PubMed ID: 24607394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling.
    Linnet J; Møller A; Peterson E; Gjedde A; Doudet D
    Addiction; 2011 Feb; 106(2):383-90. PubMed ID: 20883460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesolimbic dopamine release is linked to symptom severity in pathological gambling.
    Joutsa J; Johansson J; Niemelä S; Ollikainen A; Hirvonen MM; Piepponen P; Arponen E; Alho H; Voon V; Rinne JO; Hietala J; Kaasinen V
    Neuroimage; 2012 May; 60(4):1992-9. PubMed ID: 22348881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
    J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [To an integrative management of pathological gamblers].
    Bonnaire C
    Encephale; 2011 Dec; 37(6):410-7. PubMed ID: 22137212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered neural reward representations in pathological gamblers revealed by delay and probability discounting.
    Miedl SF; Peters J; Büchel C
    Arch Gen Psychiatry; 2012 Feb; 69(2):177-86. PubMed ID: 22310505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of gambling is associated with severity of depressive symptoms in pathological gamblers.
    Rømer Thomsen K; Callesen MB; Linnet J; Kringelbach ML; Møller A
    Behav Pharmacol; 2009 Sep; 20(5-6):527-36. PubMed ID: 19654506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers.
    Fong T; Kalechstein A; Bernhard B; Rosenthal R; Rugle L
    Pharmacol Biochem Behav; 2008 May; 89(3):298-303. PubMed ID: 18261787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance in the sensitivity to different types of rewards in pathological gambling.
    Sescousse G; Barbalat G; Domenech P; Dreher JC
    Brain; 2013 Aug; 136(Pt 8):2527-38. PubMed ID: 23757765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental analysis of the game in pathological gamblers: effect of the immediacy of the reward in slot machines.
    Chóliz M
    J Gambl Stud; 2010 Jun; 26(2):249-56. PubMed ID: 19882307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.